A King's College London clinical trial involving the cannabis compound CBD has shown it may be beneficial in treating psychosis in schizophrenia. While cannabis can pose a risk to people with schizophrenia, this is thought to be primarily due to the effects tetrahydrocannabinol (THC), the psychoactive ...

Research suggests cannabidiol could possess analgesic and anti-inflammatory properties, and is also believed to reduce anxiety and lower the incidence of seizures. While cannabidiol has grown popular among medicinal cannabis users, cannabidiol-dominant strains were not historically produced in ...

Researchers have examined the health properties of Cannabidiol (CBD) – which is the non-psychoactive ingredient in marijuana – and ruled that there is now evidence to support claims it may help treat epilepsy and “a number of other medical conditions”. Available legally on the open market, CBD is ...

Georgetown Market offers this example of cannabidiol oil, also known as CBD, Indianapolis, Friday, September 1, 2017. ... Eric Holcomb is directing state excise police to resume checking stores for cannabidiol, or CBD, products after Attorney General Curtis Hill issued an opinion declaring them illegal ...

... in Bogotá in accordance with a company's production potential, Khiron Colombia SAS has now acquired the regulatory approval necessary to start growing what it characterized as “a variety of medical grade cannabis strains,” including tetrahydrocannabinol (THC) and cannabidiol (CBD) strains.